SBRA

$19.740.66%0.13

Sabra Healthcare Reit Inc (SBRA)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$19.61

Aprire:

$19.76

Volume 24 ore:

2,015,627

Volume relativo:

0.90

Capitalizzazione di mercato:

$5.04B

Reddito:

$810.81M

Utile/perdita netta:

$156.02M

Rapporto P/E:

31.24

EPS:

$0.6319

Flusso di cassa netto:

$373.47M

1W Prestazione:

-0.20%

1M Prestazione:

+3.03%

6M Prestazione:

-3.05%

1Y Prestazione:

+10.77%

Intervallo 1D:

$0.00$0.00

Intervallo di 1 settimana:

$18.89$19.96

Portata 52W:

$17.25$22.77

Profilo aziendale di Sabra Healthcare Reit Inc (SBRA)

Nome

Sabra Healthcare Reit Inc

Settore

Real Estate

Industria

REIT - Healthcare Facilities

Telefono

888-393-8248

Indirizzo

1781 FLIGHT WAY, TUSTIN, CA, USA

Dipendente

Prossima data di guadagno

2026-11-02

Ultimi documenti SEC

SEC

Discussioni di SBRA su X

Confronta SBRA con WELL, VTR, OHI, DOC, AHR

Azioni	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SBRA Sabra Healthcare Reit Inc	$5.04B	$810.81M	$156.02M	$373.47M	$0.6319
WELL Welltower Inc	$172.10B	$11.75B	$1.46B	$2.19B	-$0.6014
VTR Ventas Inc	$44.84B	$6.13B	$272.21M	$1.38B	$0.5521
OHI Omega Healthcare Investors Inc	$14.24B	$1.24B	$655.98M	$857.80M	$2.06
DOC Healthpeak Properties Inc	$13.12B	$2.87B	$250.10M	$1.13B	$0.3188
AHR American Healthcare Reit Inc	$11.67B	$2.37B	$101.67M	$169.19M	$0.5775

Sabra Healthcare Reit Inc Azioni (SBRA) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-09-10	Iniziato	Huntington	Outperform
2026-08-06	Aggiornamento	Raymond James	Underperform → Mkt Perform
2026-07-08	Downgrade	Truist	Buy → Hold
2026-07-07	Iniziato	Barclays	Overweight
2026-06-23	Downgrade	Citigroup	Buy → Neutral
2026-06-17	Resumed	Raymond James	Underperform
2025-11-18	Iniziato	UBS	Neutral
2025-10-01	Iniziato	Cantor Fitzgerald	Neutral
2025-01-17	Downgrade	Truist	Buy → Hold
2025-01-07	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2024-12-05	Downgrade	Mizuho	Outperform → Neutral
2024-10-01	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-09-13	Aggiornamento	Citigroup	Neutral → Buy
2024-01-30	Iniziato	Deutsche Bank	Buy
2023-10-17	Downgrade	BMO Capital Markets	Outperform → Market Perform
2023-10-16	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2023-10-10	Aggiornamento	BofA Securities	Neutral → Buy
2023-10-03	Iniziato	Wedbush	Outperform
2023-09-20	Aggiornamento	Jefferies	Hold → Buy
2023-08-11	Aggiornamento	BofA Securities	Underperform → Neutral
2023-07-27	Iniziato	Berenberg	Hold
2023-04-20	Iniziato	Wells Fargo	Underweight
2022-12-13	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2022-11-14	Downgrade	BofA Securities	Neutral → Underperform
2022-10-10	Downgrade	Robert W. Baird	Outperform → Neutral
2022-06-30	Downgrade	Jefferies	Buy → Hold
2022-06-03	Iniziato	CapitalOne	Equal Weight
2022-05-25	Aggiornamento	Mizuho	Neutral → Buy
2022-04-18	Downgrade	Barclays	Overweight → Equal Weight
2022-03-11	Aggiornamento	BofA Securities	Underperform → Neutral
2022-02-18	Iniziato	KeyBanc Capital Markets	Sector Weight
2022-02-01	Iniziato	Credit Suisse	Neutral
2021-10-08	Iniziato	Robert W. Baird	Outperform
2021-09-30	Aggiornamento	Truist	Hold → Buy
2021-07-14	Resumed	Mizuho	Neutral
2021-05-21	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2021-05-10	Aggiornamento	Stifel	Hold → Buy
2021-01-13	Aggiornamento	Jefferies	Hold → Buy
2021-01-13	Downgrade	Mizuho	Buy → Neutral
2021-01-08	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2020-12-03	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2020-09-02	Resumed	Stifel	Hold
2020-06-23	Aggiornamento	Scotiabank	Sector Underperform → Sector Perform
2020-06-08	Resumed	JMP Securities	Mkt Perform
2020-05-18	Aggiornamento	Berenberg	Hold → Buy
2020-03-23	Downgrade	BofA/Merrill	Neutral → Underperform
2020-02-26	Aggiornamento	Mizuho	Neutral → Buy
2020-02-05	Iniziato	Berenberg	Hold
2019-12-20	Iniziato	Mizuho	Neutral
2019-12-18	Aggiornamento	Citigroup	Sell → Neutral
2019-10-14	Resumed	BofA/Merrill	Neutral
2019-09-23	Downgrade	Citigroup	Neutral → Sell
2019-09-03	Iniziato	Barclays	Overweight
2018-12-18	Downgrade	SunTrust	Buy → Hold
2018-11-16	Downgrade	BofA/Merrill	Neutral → Underperform
2018-05-21	Aggiornamento	Raymond James	Mkt Perform → Outperform
2018-03-26	Aggiornamento	BofA/Merrill	Underperform → Neutral
2018-02-22	Reiterato	Stifel	Hold
2017-12-21	Downgrade	Jefferies	Buy → Hold
2017-09-25	Iniziato	CapitalOne	Equal Weight

Sabra Healthcare Reit Inc Azioni (SBRA) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	774.63	703.24	647.51	624.81	569.55
Operating expenses USD (M)	-	-	628.86	603.14	488.88
Operating income USD (M)	-	-	18.66	21.67	80.67
Income before tax USD (M)	153.42	128.11	18.66	21.67	80.67
Income tax expense USD (M)	1.84	1.01	2.00	1.24	1.85
Net income USD (M)	155.51	126.71	13.76	-77.61	-113.26
Basic EPS USD/shares	0.64	0.54	0.06	-0.34	-0.52
Diluted EPS USD/shares	0.64	0.54	0.06	-0.34	-0.52
Basic weighted shares shares (M)	241.31	233.50	231.20	230.95	219.07
Diluted weighted shares shares (M)	244.50	236.05	232.79	230.95	219.07

Sabra Healthcare Reit Inc Azioni (SBRA) insider trading

Richard K. MatrosSep 08 '26
CEO
Transazione
Proposed Sale
Costo
$20.75
#Azioni
200,000
Valore ($)
4,150,000
#Azioni Totale
0
FLORES JESSICAMar 25 '26
Executive VP & CAO
Transazione
Sale
Costo
$19.86
#Azioni
15,231
Valore ($)
302,488
#Azioni Totale
71,709

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Richard K. Matros	CEO	Sep 08 '26	Proposed Sale	$20.75	200,000	4,150,000	0
FLORES JESSICA	Executive VP & CAO	Mar 25 '26	Sale	$19.86	15,231	302,488	71,709

Sabra Healthcare Reit Inc Borsa (SBRA) Ultime notizie

Oct 27, 2026